19.81
Schlusskurs vom Vortag:
$20.16
Offen:
$20.09
24-Stunden-Volumen:
1.25M
Relative Volume:
0.36
Marktkapitalisierung:
$4.71B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
23.33
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
+3.28%
1M Leistung:
+28.89%
6M Leistung:
-0.65%
1J Leistung:
+2.56%
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ADMA
Adma Biologics Inc
|
19.81 | 4.79B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.49 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.28 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.21 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
898.86 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.53 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
Technical Reactions to ADMA Trends in Macro Strategies - news.stocktradersdaily.com
ADMA Biologics, Inc. (NASDAQ:ADMA) Looks Just Right With A 25% Price Jump - simplywall.st
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - sharewise.com
Elo Mutual Pension Insurance Co Buys 25,267 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Published on: 2025-11-29 10:13:00 - moha.gov.vn
What analysts say about ADMA Biologics Inc stockMarket Sentiment Report & No Fee. No Catch. Just Smart Investment Ideas - earlytimes.in
Guidance Update: How ADMA Biologics Inc. stock valuations compare to rivals2025 AllTime Highs & Fast Gain Swing Alerts - moha.gov.vn
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 60.24%: Read This Before Placing a Bet - Zacks Investment Research
ADMA Biologics (ADMA): Assessing Valuation as Short Interest Declines and Market Sentiment Improves - Sahm
Where Will Sharp Investments Limited Stock Be in YEAR5 Growth ForecastExit Strategy Tips & These Stocks Are Just Getting Started - earlytimes.in
Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average - sharewise.com
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - sharewise.com
Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know - sharewise.com
What's Driving the Market Sentiment Around ADMA Biologics Inc? - Benzinga
High Growth Tech Stocks In The US For November 2025 - Yahoo Finance
Arihant Foundations Housing Limited Testing Reversal Zone on Weekly ChartLong-Term Growth Stocks & Breakout Stock Alerts - earlytimes.in
Adma Biologics (ADMA) CEO Grossman sells $336k in shares By Investing.com - Investing.com South Africa
ADMA Biologics CEO Adam S Grossman Sells Shares - TradingView
[Form 4] ADMA BIOLOGICS, INC. Insider Trading Activity - Stock Titan
Adma Biologics (ADMA) CEO Grossman sells $336k in shares - Investing.com
CEO Grossman Sells 21,000 ($336K) Of Adma Biologics Inc [ADMA] - TradingView
Trading the Move, Not the Narrative: (ADMA) Edition - news.stocktradersdaily.com
ADMA Biologics: Why The Dip To $16 Resets The Buy Case (NASDAQ:ADMA) - Seeking Alpha
Why ADMA Biologics Inc. stock appeals to analysts2025 Price Targets & Risk Controlled Daily Plans - newser.com
Building trade automation scripts for ADMA Biologics Inc.Earnings Growth Summary & Daily Technical Forecast Reports - newser.com
ADMA Biologics Inc (ADMA) Stock forecasts - Yahoo Finance UK
ADMA Biologics (ADMA) Is Up 7.2% After Raised Guidance and Share Buybacks Has the Bull Case Changed? - Sahm
Will ADMA Biologics Inc. stock continue dividend increases2025 Trading Volume Trends & Stock Timing and Entry Methods - newser.com
Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com
Applying Wyckoff theory to ADMA Biologics Inc. stock2025 Performance Recap & Stepwise Trade Execution Plans - newser.com
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - sharewise.com
Risk adjusted return profile for ADMA Biologics Inc. analyzedJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
ADMA Biologics, Inc. (ADMA) Stock Price Quote Today & Current Price Chart - Capital.com
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors - sharewise.com
Why ADMA Biologics' (NASDAQ:ADMA) Earnings Are Weaker Than They Seem - Yahoo Finance
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade - sharewise.com
(ADMA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Adma Biologics Shares Maintain Upward Momentum on Strong Financial Performance - AD HOC NEWS
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Nov 19 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,013,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,040,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,019,850 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):